This study discusses other triggers that may be relevant. we must take on board that SGLT-2 medications are now being prescribed as a prophylactic to those at higher risk of cardio event, and this may include T1D in the future. There is also the possibility that weight loss injections may also trigger these events because they also increase glucagon levels and have reported occurrences of gastroparesis. I note that bariatric surgery is also a risk factor.As a T1 I've ;always been told that DKA was caused by insufficient insulin and that high bgs and ketones were a marker. (Admittedly, my consultant was horrified when I told her a few years ago that I'd never really tested for ketones, and promptly gave me a glucometer that could test for them. (And I haven't had a DKA in 53 years of T1, don't know if that is luck or not).
So, assuming no other meds than insulin, is a T1 actually more likely to go into euDKA than a non diabetic? (Assuming that a T1 is injecting insulin to maintain their bgs and therefore presumably not low on the stuff)
Non-medication causes of euDKA appear to be starvation, pregnancy or a weird metabolosm.. I'm not sure whether a T1 is more likely to have any of those than a non diabetic?
Hi @OldvatrThis study discusses other triggers that may be relevant. we must take on board that SGLT-2 medications are now being prescribed as a prophylactic to those at higher risk of cardio event, and this may include T1D in the future. There is also the possibility that weight loss injections may also trigger these events because they also increase glucagon levels and have reported occurrences of gastroparesis. I note that bariatric surgery is also a risk factor.
So, users of low carb / keto diets who are insulin dependant should also be aware of possibility of euDKA , but I doubt if that message is being dispensed. It seems it is not.
The SGLT-2 experience in T2D shows that controlling to a low level of bgl can allow gluconeogenesis from ketones to reach euDKA levels and not the higher DKA levels but enough to turn the blood acidic. This same mechanism could apply to T1D. I have seen warnings from an SGLT-2 study on euDKA from it that they suggest that controlling below 7 mmol.l does increase the risk of euDKA, which is why Low Carb is contraindicated for those meds.
A google search got me some results.I'm pretty good at reading physiology and biochemistry papers but have never come across anything citing increased glucagon production in T1 diabetics
Even if T1s not on flozins but on insulin only are theoretically able to go into eDKA in the absence of underlying illness, does it actually happen in real life or not?This study discusses other triggers that may be relevant. we must take on board that SGLT-2 medications are now being prescribed as a prophylactic to those at higher risk of cardio event, and this may include T1D in the future. There is also the possibility that weight loss injections may also trigger these events because they also increase glucagon levels and have reported occurrences of gastroparesis. I note that bariatric surgery is also a risk factor.
So, users of low carb / keto diets who are insulin dependant should also be aware of possibility of euDKA , but I doubt if that message is being dispensed. It seems it is not.
The SGLT-2 experience in T2D shows that controlling to a low level of bgl can allow gluconeogenesis from ketones to reach euDKA levels and not the higher DKA levels but enough to turn the blood acidic. This same mechanism could apply to T1D. I have seen warnings from an SGLT-2 study on euDKA from it that they suggest that controlling below 7 mmol.l does increase the risk of euDKA, which is why Low Carb is contraindicated for those meds.
Your Endo has IMO given you the headsup you need and made you aware that it may be possible, and so you can take appropriate counter measures if it ever does occur. That is why I beleive this conversation should happen, but does not seem to be part of the current education. Perhaps Daphne needs updating in line of current trends and research findings.Hi @Oldvatr
I'm pretty good at reading physiology and biochemistry papers but have never come across anything citing increased glucagon production in T1 diabetics, if you can provide some references that would be great.
I'm sure our experiences do differ, but pragmatically I'd refuse a SGLT-2 inhibitor even if suggested (which of course they are not recommended for T1 ).
Insulin can be a very dangerous drug but it is also extremely flexible for achieving good blood glucose control - however this also requires constant attention and re-tweeking doses and I would now be lost without my CGM to fine tune dosing. I've done a DAFNE course but could not stand the extra high insulin shots for high carbs. Low carb/keto is much easier for day to day life.
In fairness my endocrinologist last year did discuss in depth with me how would I identify eDKA give my preferred low carb/keto diet. He was reassured when I said that I would be relying on symptoms of severe acidosis, not ketones nor high bg levels - I know when to self treat and when to call 999.
Probably an area all diabetics whether T1 or T2 could use more information about.
Here is a treatise on T1D and glucagon.A google search got me some results.
But even if we do produce more glucagon than average, having normal BG (euglyceamic, which is what this thread is about) proves we can adjust our insulin doses for this.
Even if T1s not on flozins but on insulin only are theoretically able to go into eDKA in the absence of underlying illness, does it actually happen in real life or not?
Can you find anything on T1s going into DKA on a keto type diet, insulin only, while maintaining normal BG?
Dehydration has the effect of increasing concentration ofDr Bernstein thinks DKA is about dehydration.
High blood glucose or high ketones will accelerate dehydration. If you are constantly being sick you will be unable to rehydrate quick enough and require medical assistance.
17 mmol/l is definitely not seen as euglyceamic, and many T1s are told to test for ketones when above 13 or 15 for a prolonged time, not 20.one of the studies I linked earlier did report bgl levels of around 17 being found to be DKA.
You're still talking about diabetics with hyperglyceamia and DKA, not eDKA.Yes T1D can adjust insulin dose to reduce glucose levels, and this may be sufficient, but there are a lot of T1D who either cannot or may not realise they need to, Not everyone is able to recognise hyperglycemia, and I personally walked around with levels above 32mmol/l and felt fit and healthy with no side effects. insulin bolus after the event takes time to act so is not the quickest route out of DKA if it starts.
And you are talking about healthy T1D able to dose adjust, and using copious monitoring, including the new and expensive CGM. Are you sure this applies to the majority of T1D? It is not what my T1D friends experience.17 mmol/l is definitely not seen as euglyceamic, and many T1s are told to test for ketones when above 13 or 15 for a prolonged time, not 20.
You're still talking about diabetics with hyperglyceamia and DKA, not eDKA.
T1's as a rule do not rely on how they feel to recognise a high level, we test. And many of us use CGM and we'll get an alarm when we rise.
There is a lot about DAFNE that I feel needs review/updating (but in fairness it has taught me a few things and improved my carb & protein counting/bolusing). Also the course coordinator was the one that had me issued a ketone meter once she knew I favoured low carb.Your Endo has IMO given you the headsup you need and made you aware that it may be possible, and so you can take appropriate counter measures if it ever does occur. That is why I beleive this conversation should happen, but does not seem to be part of the current education. Perhaps Daphne needs updating in line of current trends and research findings.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?